Humana Inc. lost an administrative appeal in its ongoing battle to reverse changes to Medicare quality ratings that threaten ...

The consensus estimate has shifted 41.68% due to these changes. Currently, Humana has a poor Growth ... putting it in the top 20% for this investment strategy. Overall, the stock has an aggregate ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Guggenheim analyst Jason Cassorla initiated coverage of Humana (HUM) with a Buy rating and $326 price target The firm launched coverage on 11 ...

HUM’s investment in comprehensive musculoskeletal services supports its long-term growth strategy and competitive edge in senior healthcare. Shares of Humana have gained 12.1% over the past ...

The CMS announced a 5.06% expected average change in revenue for 2026 Medicare ... of pressure on many insurance stocks last year. But Humana Inc.'s stock (HUM) rose more than 11% in Monday's ...

Harbour Investments Inc.’s holdings in Humana were worth $80,000 as of its most recent SEC filing. A number of other hedge funds also recently bought and sold shares of HUM.

Humana, the second-largest MA payer, lost the most lives during open enrollment, falling from 6.2 million to 5.8 million enrollees. The data provides the first peek at MA enrollment changes ...